New Zenith MD&A Posted on SEDAR
|
5
|
Zenith Epigenetics
|
Sep 27, 2017 03:44PM
|
Newbies Welcome Wagon....
|
5
|
Resverlogix Corp.
|
Apr 22, 2019 12:59PM
|
News at BIO International next week?
|
5
|
Resverlogix Corp.
|
Jun 01, 2018 12:01PM
|
News release 8/31/15 regarding new data presented at ESC 2015
|
5
|
Resverlogix Corp.
|
Aug 31, 2015 09:41AM
|
News Release from ERA-EDTA Conference
|
3
|
Resverlogix Corp.
|
Jun 01, 2015 08:12AM
|
News Release: RESVERLOGIX ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES
|
1
|
Resverlogix Corp.
|
Sep 12, 2016 07:22AM
|
Next up.....
|
1
|
Resverlogix Corp.
|
May 02, 2018 05:28PM
|
Nice article on orphan/pediatric disease FDA voucher program
|
2
|
Resverlogix Corp.
|
Sep 18, 2015 03:53PM
|
Nichols review of SUSTAIN and ASSURE
|
1
|
Resverlogix Corp.
|
Dec 05, 2016 04:20PM
|
NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
3
|
Resverlogix Corp.
|
May 21, 2018 11:06PM
|
NLRP3 inhibitors and apabetalone
|
8
|
Resverlogix Corp.
|
Jul 26, 2019 01:10PM
|
NLRP3 inhibitors stoke anti-inflammatory ambitions
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 12:00PM
|
No ESC 2019 Late Breaker
|
7
|
Resverlogix Corp.
|
Jun 26, 2019 09:25AM
|
No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:08PM
|
No show at Rodman and Renshaw?
|
5
|
Resverlogix Corp.
|
Sep 11, 2017 02:51PM
|
Norman Wong presenting at Alberta Epigenetics Network Summit 3/22
|
6
|
Resverlogix Corp.
|
Mar 21, 2016 11:25AM
|
Not all top-line news releases look the same
|
3
|
Resverlogix Corp.
|
Jun 18, 2019 02:58PM
|
Not even on the radar in this "state of the art" review
|
3
|
Resverlogix Corp.
|
Jun 20, 2018 11:52AM
|
Not good for the potential of apabetalone as a Covid-19 therapy
|
9
|
Resverlogix Corp.
|
Nov 29, 2021 02:29PM
|
Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 15, 2016 11:15PM
|